Literature DB >> 21178328

False positive newborn screening results are not always benign.

D R Morrison1, E W Clayton.   

Abstract

OBJECTIVE: Our goal was to assess the impact on families of receiving abnormal newborn screening results. PATIENTS AND METHODS: We conducted telephone interviews with parents of 3 groups of children who had received abnormal newborn screening results: (1) false positive but otherwise healthy (FP, n = 28), (2) true positive (TP, n = 20), and (3) false positive with other medical conditions (FP + other, n = 12). Interviews, based on the instruments developed by Waisbren et al. [J Pediatr Psychol 2004;29:565-570], included open- and close-ended questions as well as the Parental Stress Index (PSI).
RESULTS: In response to open ended questions, FP parents expressed concern about having more children and identified numerous problems with how they were told about newborn screening. Parents of FP + other reported the most stress, followed by parents of children with metabolic disease. Nonetheless, almost 10% of FP parents reported clinically significant stress as well as worry about their child's health and future.
CONCLUSIONS: False positive newborn screening results cause some parents to experience stress and long-term worry. Although more work is needed to learn how well these sequelae can be averted by more effective communication in the pre- and postnatal periods, these effects need to be considered in deciding whether to add new disorders to newborn screening panels.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 21178328     DOI: 10.1159/000322527

Source DB:  PubMed          Journal:  Public Health Genomics        ISSN: 1662-4246            Impact factor:   2.000


  2 in total

Review 1.  The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic Review.

Authors:  Stuart J Wright; Cheryl Jones; Katherine Payne; Nimarta Dharni; Fiona Ulph
Journal:  Appl Health Econ Health Policy       Date:  2015-12       Impact factor: 2.561

2.  The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study.

Authors:  Maria D Karaceper; Pranesh Chakraborty; Doug Coyle; Kumanan Wilson; Jonathan B Kronick; Steven Hawken; Christine Davies; Marni Brownell; Linda Dodds; Annette Feigenbaum; Deshayne B Fell; Scott D Grosse; Astrid Guttmann; Anne-Marie Laberge; Aizeddin Mhanni; Fiona A Miller; John J Mitchell; Meranda Nakhla; Chitra Prasad; Cheryl Rockman-Greenberg; Rebecca Sparkes; Brenda J Wilson; Beth K Potter
Journal:  Orphanet J Rare Dis       Date:  2016-02-03       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.